Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-30

Clinical Trial Update: Comparing UDCA and Corticosteroids in Immunotherapy Induced Cholestatic Hepatitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ursodeoxycholic acid (UDCA) to corticosteroids for immune-mediated cholestasis induced by immunotherapy. The study status is not yet rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)
  • Ursodeoxycholic acid (ursodeoxycholic acid)

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Immune-Mediated Cholestasis | Phase 2 | Status: NOT_YET_RECRUITING